Recro Pharma Earnings Surprises image   This REPH earnings surprises page last updated 3/2/2022
Recro Pharma Earnings Surprises Chart
Data adjusted for REPH split history

PeriodExpectedActualSurprise
Q4 2021 -0.07 -0.04 +0.03 (-43%)
Q2 2021 -0.11 0.03 +0.14 (-127%)
Q1 2021 -0.25 -0.23 +0.02 (-8%)
Q4 2020 -0.25 -0.48 -0.23 (+92%)
Q3 2020 -0.20 -0.09 +0.11 (-55%)
Q2 2020 -0.16 -0.25 -0.09 (+56%)
Q1 2020 -0.03 -0.33 -0.30 (+1000%)
Q4 2019 -0.25 -0.38 -0.13 (+52%)
Q3 2019 -0.19 -0.17 +0.02 (-11%)
Q2 2019 -0.38 -0.12 +0.26 (-68%)
Q1 2019 -0.95 -0.09 +0.86 (-91%)
Q4 2018 -0.67 -0.52 +0.15 (-22%)
Q3 2018 -0.63 -0.57 +0.05 (-10%)
Q2 2018 -1.20 -0.56 +0.65 (-53%)
Q1 2018 -0.63 -0.58 +0.04 (-8%)
Q4 2017 -0.92 -1.14 -0.22 (+24%)
Q3 2017 -0.67 -0.43 +0.24 (-36%)
Q2 2017 -0.48 -0.43 +0.04 (-10%)
Q1 2017 -0.52 -0.38 +0.14 (-27%)
Q2 2016 -0.70 -0.74 -0.04 (+6%)
Q1 2016 -0.59 -0.64 -0.04 (+8%)
Q4 2015 -0.39 -0.64 -0.25 (+64%)
Q3 2015 -0.18 -0.22 -0.04 (+22%)
Q2 2015 -0.20 -0.15 +0.04 (-25%)
Recro Pharma Revenue Surprises Chart
PeriodExpectedActualSurprise
Q4 2021 21.41M 22.30M +890000 (+4%)
Q2 2021 17.10M 18.02M +917000 (+5%)
Q1 2021 16.43M 16.80M +373000 (+2%)
Q4 2020 15.00M 9.91M -5.09M (-34%)
Q3 2020 16.33M 19.29M +2.96M (+18%)
Q2 2020 18.88M 15.52M -3.36M (-18%)
Q1 2020 19.45M 21.78M +2.33M (+12%)
Q4 2019 19.55M 17.64M -1.91M (-10%)
Q3 2019 20.35M 25.25M +4.91M (+24%)
Q2 2019 23.59M 31.26M +7.67M (+33%)
Q1 2019 20.51M 25.07M +4.55M (+22%)
Q4 2018 16.05M 17.78M +1.73M (+11%)
Q3 2018 16.73M 18.28M +1.55M (+9%)
Q2 2018 16.66M 21.74M +5.08M (+30%)
Q1 2018 17.74M 19.54M +1.80M (+10%)
Q4 2017 12.91M 19.04M +6.13M (+47%)
Q3 2017 13.68M 17.11M +3.43M (+25%)
Q2 2017 14.59M 16.93M +2.34M (+16%)
Q1 2017 15.17M 18.74M +3.57M (+24%)
Q2 2016 15.43M 17.28M +1.85M (+12%)
Q1 2016 13.00M 17.74M +4.74M (+36%)
Q4 2015 12.50M 16.75M +4.25M (+34%)
Q3 2015 15.25M 16.54M +1.29M (+8%)
Q2 2015 7.50M 18.66M +11.16M (+149%)
Quotes delayed 20 minutes

Email EnvelopeFree REPH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Donaldson (DCI): 3/2/2022 6:00 AM
Dycom Industries (DY): 3/2/2022 6:00 AM
Amneal Pharmaceuticals (AMRX): 3/2/2022 6:00 AM
Astronics (ATRO): 3/2/2022 6:30 AM
Jounce Therapeutics (JNCE): 3/2/2022 6:30 AM
International Seaways (INSW): 3/2/2022 6:45 AM
Patterson Companies (PDCO): 3/2/2022 7:00 AM
Hayward Holdings (HAYW): 3/2/2022 7:00 AM
Hillman Solutions Corp. - Class A Common Stock (HLMN): 3/2/2022 7:00 AM
Intercept Pharmaceuticals (ICPT): 3/2/2022 7:00 AM

More from the Next Earnings Dates Calendar

Earnings History:

Apartment Inv & Mgmt (AIV): 3/1/2022 5:00 PM
Ferro (FOE): 3/1/2022 After close
XL Fleet (XL): 3/1/2022 After close
CytomX Therapeutics (CTMX): 3/1/2022 After close
Certara (CERT): 3/1/2022 After close
GCP Applied Technologies (GCP): 3/1/2022 After close
Maui Land & Pineapple Co (MLP): 3/1/2022 After close
BRP Group (BRP): 3/1/2022 After close
Kodiak Sciences (KOD): 3/1/2022 After close
First Solar (FSLR): 3/1/2022 After close

More from the Earnings History archive
Recro Pharma (REPH) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

REPL Past Earnings
RETA Past Earnings
RGEN Past Earnings
RGLS Past Earnings
RGNX Past Earnings
RIGL Past Earnings
RLAY Past Earnings
RLMD Past Earnings
RLYB Past Earnings
RMD Past Earnings
On this page we presented the REPH earnings surprises information for Recro Pharma, comparing the expected earnings versus the actual earnings quarter by quarter, with the resulting positive or negative percentage surprise. Any self directed investor doing their due diligence on REPH (or any other given stock) can benefit from researching all of the Recro Pharma past earnings going backwards in time, including how often the company beat or missed the market's expectations. To help you with this Recro Pharma earnings surprise research, on this page we presented each quarter's resulting numbers for easy comparison. Studying these numbers can help an investor by providing important context with which to think about REPH's next earnings report. In your continued research on Recro Pharma we hope you will be sure to check out the further links included for revenue and earnings history as well as next earnings dates for REPH. Thanks for visiting, and the next time you need to research REPH earnings surprises or those of another stock, we hope you'll think of our site as your go-to earnings surprises research resource of choice.

Recommended: BRBS Insider Buying, United Parcel Service shares outstanding history, IMTX Average Annual Return.

 

Recro Pharma Earnings Surprises | www.NextEarningsDate.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.